Should You Buy, Sell or Hold RenaissanceRe Stock at a 1.34X P/B?

Zacks
2024-12-12

RenaissanceRe Holdings LtdRNR is currently trading at a discount compared to the industry average. The stock is currently trading at 1.34X, trailing 12-month tangible book value, which compares to 1.57X for the industry, indicating undervaluation. The company has a Value Score of B.


Image Source: Zacks Investment Research

In the past three months, RNR has delivered 5.9% growth, outperforming the industry’s 2.8% growth. The company’s price performance also outperformed its peers, such as First American Financial Corporation FAF and Reinsurance Group of America, Incorporated RGA, which gained 1.3% and lost 0.8%, respectively. However, it underperformed the S&P 500’s 8.5% rise.

RNR's 3-Month Price Performance


Image Source: Zacks Investment Research

Now, let’s take a look at the stock’s growth drivers.

RNR’s Growth Drivers

RenaissanceRe is actively pursuing growth through strategic acquisitions and business expansion. The recent acquisition of Validus Re and related businesses from AIG has significantly strengthened its global property and casualty reinsurance operations and enhanced profitability. The company also optimizes its portfolio by divesting non-core assets.

RNR’s strong cash position supports its growth initiatives and shareholder returns. Over the past 12 months, it generated $3.9 billion in net operating cash flow and repurchased $106.8 million in shares in the third quarter. 

Increasing premiums from its Property and Casualty & Specialty segments are expected to further drive performance. Strong underwriting results contribute to profit growth, evident in recent upward estimate revisions.

Estimate Revisions for RNR Stock

Reflecting the positive sentiment around RenaissanceRe, the Zacks Consensus Estimate for earnings per share has seen upward revisions. The consensus estimate for 2024 adjusted earnings for RNR is currently pegged at $41.94 per share, which indicates 11.7% year-over-year growth. The company beat earnings estimates in each of the past four quarters, with an average surprise of 28%. The consensus estimate for 2024 revenues suggests 36.6% year-over-year growth.


Image Source: Zacks Investment Research

Key Concerns for RNR

There are a few factors that investors should keep an eye on.

RenaissanceRe faces escalating expenses driven by higher net claims and claim expenses, acquisition costs, and operational expenses. We expect it to escalate by more than 44% on a year-over-year basis in 2024. The rising expenses pose a risk to the company’s profit margins.

The company’s long-term debt to capital of 43.9% is significantly higher than the industry average. Its debt load increased from $1.2 billion at the end of 2022 to $1.9 billion as of Sept. 30, 2024. This elevated debt level has led to a sharp rise in interest expenses, which grew 41.1% year over year in the first nine months of 2024.  

End Notes

RenaissanceRe shows strong growth potential, bolstered by strategic acquisitions like Validus Re, rising premiums, and robust underwriting results. Consistent earnings surprises and upward revisions in estimates highlight its resilience, supported by strong cash flow and share repurchases. However, escalating expenses, elevated debt levels, and rising interest costs pose challenges to profit margins. Current shareholders may consider holding on to their shares. However, potential investors may want to wait for a better entry point.

RNR stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RenaissanceRe Holdings Ltd. (RNR) : Free Stock Analysis Report

First American Financial Corporation (FAF) : Free Stock Analysis Report

Reinsurance Group of America, Incorporated (RGA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10